BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8104185)

  • 21. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
    Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the 132-160 region in prion protein conformational transitions.
    Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
    Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational change in hamster scrapie prion protein (PrP27-30) associated with proteinase K resistance and prion infectivity.
    Suzuki SY; Takata M; Teruya K; Shinagawa M; Mohri S; Yokoyama T
    J Vet Med Sci; 2008 Feb; 70(2):159-65. PubMed ID: 18319576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
    Kaneko K; Peretz D; Pan KM; Blochberger TC; Wille H; Gabizon R; Griffith OH; Cohen FE; Baldwin MA; Prusiner SB
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11160-4. PubMed ID: 7479957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain.
    Kocisko DA; Lansbury PT; Caughey B
    Biochemistry; 1996 Oct; 35(41):13434-42. PubMed ID: 8873612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease.
    Zou WQ; Capellari S; Parchi P; Sy MS; Gambetti P; Chen SG
    J Biol Chem; 2003 Oct; 278(42):40429-36. PubMed ID: 12917418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PrP27-30 is a normal soluble prion protein fragment released by human platelets.
    Perini F; Vidal R; Ghetti B; Tagliavini F; Frangione B; Prelli F
    Biochem Biophys Res Commun; 1996 Jun; 223(3):572-7. PubMed ID: 8687437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
    Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
    Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc.
    Thackray AM; Hopkins L; Klein MA; Bujdoso R
    J Virol; 2007 Nov; 81(22):12119-27. PubMed ID: 17728226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mechanisms of degeneration of the central nervous system--prion structure and biology.
    Prusiner SB; Stahl N; DeArmond SJ
    Ciba Found Symp; 1988; 135():239-60. PubMed ID: 2900720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creutzfeldt-Jakob disease and scrapie prions.
    Prusiner SB
    Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
    Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
    EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
    Mehlhorn I; Groth D; Stöckel J; Moffat B; Reilly D; Yansura D; Willett WS; Baldwin M; Fletterick R; Cohen FE; Vandlen R; Henner D; Prusiner SB
    Biochemistry; 1996 Apr; 35(17):5528-37. PubMed ID: 8611544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
    Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
    J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the biology of prions.
    Prusiner SB; Gabizon R; McKinley MP
    Acta Neuropathol; 1987; 72(4):299-314. PubMed ID: 3554880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The deletion of amino acids 114-121 in the TM1 domain of mouse prion protein stabilizes its conformation but does not affect the overall structure.
    Thaa B; Zahn R; Matthey U; Kroneck PM; Bürkle A; Fritz G
    Biochim Biophys Acta; 2008 Jun; 1783(6):1076-84. PubMed ID: 18088603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
    Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
    J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.